SEMIN ONCOL
Publications
- 2022
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time
Hoeh, B., Flammia, R. S., Hohenhorst, L., Sorce, G., Panunzio, A., Tappero, S., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Terrone, C., Shariat, S. F., Graefen, M., Tilki, D., Antonelli, A., Kosiba, M., Kluth, L. A., Becker, A., Chun, F. K. H. & Karakiewicz, P. I., 10.2022, In: SEMIN ONCOL. 49, 5, p. 394-399 6 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer, C., Harstrick, A., Beyer, J., Metzner, B., Rüther, U., Hartmann, J. T., Holstein, K., Derigs, H. G., de Wit, R., Casper, J., Schöffski, P., Kührer, I., Illiger, H. J., Kempf, B., Reichle, A., Föller, A., Hossfeld, D. K., Fischer, J. T., Berdel, W. E., Gerhartz, H. H., Kirchner, H., Pflüger, K. H., Ostermann, H., Kanz, L. & Schmoll, H. J., 1998, In: SEMIN ONCOL. 25(2 Suppl 4), p. 24-28Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review